Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. (CRXTQ) Revenue
Annual & quarterly revenue history · segment & region breakdown
CRXTQ · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsClarus Therapeutics Holdings, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Clarus Therapeutics Holdings, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Clarus Therapeutics Holdings, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Clarus Therapeutics Holdings, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CRXTQ revenue · 4 questionsCRXTQ's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Clarus Therapeutics Holdings, Inc. SEC filings · GAAP · Clarus Therapeutics Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026